314764-23-3 Usage
Uses
Used in Pharmaceutical Industry:
2-(benzylsulfanyl)-4-(4-methoxyphenyl)-6-phenylnicotinonitrile is used as a drug candidate for its potential therapeutic effects. 2-(benzylsulfanyl)-4-(4-methoxyphenyl)-6-phenylnicotinonitrile's unique structural features and pharmacological properties make it a promising candidate for the development of new medications to treat a range of medical conditions, pending further research and clinical trials.
Used in Research and Development:
In the field of scientific research, 2-(benzylsulfanyl)-4-(4-methoxyphenyl)-6-phenylnicotinonitrile serves as a subject for exploring its biological activities and potential mechanisms of action. Its study contributes to the advancement of knowledge in medicinal chemistry and could lead to the discovery of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 314764-23-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,4,7,6 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 314764-23:
(8*3)+(7*1)+(6*4)+(5*7)+(4*6)+(3*4)+(2*2)+(1*3)=133
133 % 10 = 3
So 314764-23-3 is a valid CAS Registry Number.
314764-23-3Relevant academic research and scientific papers
Unexpected formation of 4-aryl-3-cyano-6-phenylpyridine-2(1H)-thiones from the reaction of arylmethylenecyanothioacetamides with benzoyl-1,1,1- trifluoroacetone
Dyachenko,Chernega
, p. 1499 - 1506 (2007/10/03)
4-Aryl-3-cyano-6-phenylpyridine-2(1H)-thiones, used in the synthesis of substituted 2-alkylthiopyridines, thieno[2,3-b]pyridines, and 1,4-di(pyridin-2-ylthio)butane, have been synthesized by the condensation of arylmethylenecyanothioacetamides with benzoyl-1,1,1-trifluoroacetone. The reaction path includes the formation of the Michael adduct which undergoes loss of the acyl group. The structure of 3-cyano-2-methylthio-4-(1-naphthyl)-6- phenylpyridine has been studied by X-ray crystallography. 2005 Springer Science+Business Media, Inc.